ADHERENCE AND PERSISTENCE OF ORAL ANTICOAGULANTS FOR TREATMENT OF ATRIAL FIBRILLATION ACROSS STROKE AND BLEEDING RISK STRATA

被引：0
|
作者：
Ko, G. [1 ]
Brouwer, E. [2 ]
Dayer, V [3 ]
Katta, A. [4 ]
Ramsey, S. [2 ]
Lopes, M. [5 ]
Singh, R. [1 ]
Kong, S. X. [1 ]
机构：
[1] Bayer US LLC, Whippany, NJ USA
[2] Curta Inc, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Bayer Healthcare Pharmaceut Inc, Jersey City, NJ USA
[5] MMDLOPES LLC, Cresskill, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR233
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [41] Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation
    Zotova, I. V.
    Zateyshchikov, D. A.
    KARDIOLOGIYA, 2011, 51 (10) : 81 - 91
  • [42] Association of Type of Antidepressant With Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants
    Shao, Iris Yuefan
    Claxton, J'Neka S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Alonso, Alvaro
    CIRCULATION, 2019, 139
  • [43] Prescribing Errors With Direct Oral Anticoagulants and Their Impact on the Risk of Bleeding in Patients With Atrial Fibrillation
    Raccah, Bruria Hirsh
    Erlichman, Yevgeni
    Pollak, Arthur
    Matok, Ilan
    Muszkat, Mordechai
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (06) : 601 - 610
  • [44] New Bleeding Risk Prediction Model for Patients with Atrial Fibrillation on Direct Oral Anticoagulants
    Tanaka, Yoshihiro
    Lancki, Nicola
    Khan, Sadiya
    Martin, Karlyn
    Passman, Rod S.
    CIRCULATION, 2021, 144
  • [45] Adherence with direct oral anticoagulants in patients with atrial fibrillation: Trends, risk factors, and outcomes
    Arbel, Anat
    Abu-Ful, Zomoroda
    Preis, Meir
    Cohen, Shai
    Saliba, Walid
    JOURNAL OF ARRHYTHMIA, 2022, 38 (01) : 67 - 76
  • [46] Is there a difference in treatment persistence across oral anticoagulants? Results of a UK cohort study evaluating oral anticoagulation therapy in an atrial fibrillation population
    Lacoin, L.
    Johnson, M.
    Johnson, M.
    Johnson, M.
    Collings, S. L.
    Collings, S. L.
    Collings, S. L.
    Lefevre, C.
    Lefevre, C.
    Lefevre, C.
    Kloss, S.
    Kloss, S.
    Kloss, S.
    Parsons, V.
    Parsons, V.
    Parsons, V.
    Maguire, A.
    Maguire, A.
    Maguire, A.
    Stynes, G.
    Stynes, G.
    Stynes, G.
    Ridha, E.
    Ridha, E.
    Ridha, E.
    EUROPEAN HEART JOURNAL, 2016, 37 : 493 - 493
  • [47] Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants
    Rasmussen, Peter Vibe
    Hylek, Elaine
    EUROPEAN HEART JOURNAL, 2021, 42 (40) : 4138 - 4140
  • [48] Association of Depression and Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
    Lapa, Matthew
    Magnani, Jared W.
    CIRCULATION, 2022, 146
  • [49] Real-world adherence to oral anticoagulants in atrial fibrillation
    Simonyi Gabor
    Paksy Andras
    Varnai Reka
    Medvegy Mihaly
    ORVOSI HETILAP, 2020, 161 (20) : 839 - 845
  • [50] Assessment of adherence, treatment satisfaction and knowledge of direct oral anticoagulants in atrial fibrillation patients
    Moudallel, Souad
    van Laere, Sven
    Cornu, Pieter
    Dupont, Alain
    Steurbaut, Stephane
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2419 - 2429
12345